Is Contrast Medium Really Needed for Follow-up MRI of Untreated Intracranial Meningiomas?

References

1. 1.↵
   2. Prince MR,
   3. Zhang H,
   4. Zou Z, et al

   . Incidence of immediate gadolinium contrast media reactions. AJR Am J Roentgenol 2011;196:W138–43 doi:10.2214/AJR.10.4885 pmid:21257854

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Granata V,
   3. Cascella M,
   4. Fusco R, et al

   . Immediate adverse reactions to gadolinium-based MR contrast media: a retrospective analysis on 10,608 examinations. BioMed Res Int 2016;2016:3918292 doi:10.1155/2016/3918292 pmid:27652261

   CrossRefPubMed
3. 3.↵
   2. Kanda T,
   3. Ishii K,
   4. Kawaguchi H, et al

   . High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 2014;270:834–41 doi:10.1148/radiol.13131669 pmid:24475844

   CrossRefPubMed
4. 4.↵
   2. Kanda T,
   3. Osawa M,
   4. Oba H, et al

   . High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology 2015;275:803–09 doi:10.1148/radiol.14140364 pmid:25633504

   CrossRefPubMed
5. 5.↵
   2. Quattrocchi CC,
   3. Mallio CA,
   4. Errante Y, et al

   . Gadodiamide and dentate nucleus T1 hyperintensity in patients with meningioma evaluated by multiple follow-up contrast-enhanced magnetic resonance examinations with no systemic interval therapy. Invest Radiol 2015;50:470–72 doi:10.1097/RLI.0000000000000154 pmid:25756685

   CrossRefPubMed
6. 6.↵
   2. Ramalho J,
   3. Semelka RC,
   4. Ramalho M, et al

   . Gadolinium-based contrast agent accumulation and toxicity: an update. AJNR Am J Neuroradiol 2016;37:1192–98 doi:10.3174/ajnr.A4615 pmid:26659341

   Abstract/FREE Full Text
7. 7.↵
   2. Stojanov D,
   3. Aracki-Trenkic A,
   4. Benedeto-Stojanov D

   . Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents—current status. Neuroradiology 2016;58:433–41 doi:10.1007/s00234-016-1658-1 pmid:26873830

   CrossRefPubMed
8. 8.↵
   2. Huber M,
   3. Orosz E

   . Health expenditure trends in OECD countries. Health Care Financ Rev 2003;25:1–22 pmid:14997690

   PubMed
9. 9.↵
   2. Reinhardt UE,
   3. Hussey PS,
   4. Anderson GF

   . U.S. health care spending in an international context. Health Aff (Millwood) 2004;23:10–25 doi:10.1377/hlthaff.23.3.10 pmid:15160799

   Abstract/FREE Full Text
10. 10.↵
    2. Dunnick NR,
    3. Applegate KE,
    4. Arenson RL

    . The inappropriate use of imaging studies: a report of the 2004 Intersociety Conference. J Am Coll Radiology 2005;2:401–06 doi:10.1016/j.jacr.2004.12.008 pmid:17411843

    CrossRefPubMed
11. 11.↵
    2. Goldbrunner R,
    3. Minniti G,
    4. Preusser M, et al

    . EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 2016;17:e383–91 doi:10.1016/S1470-2045(16)30321-7 pmid:27599143

    CrossRefPubMed
12. 12.↵
    2. Buetow MP,
    3. Buetow PC,
    4. Smirniotopoulos JG

    . Typical, atypical, and misleading features in meningioma. Radiographics 1991;11:1087–106 doi:10.1148/radiographics.11.6.1749851 pmid:1749851

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Russell EJ,
    3. George AE,
    4. Kricheff II, et al

    . Atypical computed tomography features of intracranial meningioma: radiological-pathological correlation in a series of 131 consecutive cases. Radiology 1980;135:673–82 doi:10.1148/radiology.135.3.7384454 pmid:7384454

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Ostrom QT,
    3. Gittleman H,
    4. Fulop J, et al

    . CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2012-2016. Neuro Oncol 2019;21(Suppl 5):v1–100 doi:10.1093/neuonc/nov189 pmid:31675094

    CrossRefPubMed
15. 15.↵
    2. Wood MW,
    3. White RJ,
    4. Kernohan JW

    . One hundred intracranial meningiomas found incidentally at necropsy. J Neuropathol Exp Neurol 1957;16:337–40 doi:10.1097/00005072-195707000-00005 pmid:13439397

    CrossRefPubMed
16. 16.↵
    2. Nakamura M,
    3. Roser F,
    4. Michel J, et al

    . Volumetric analysis of the growth rate of incompletely resected intracranial meningiomas. Zentralbl Neurochir 2005;66:17–23 doi:10.1055/s-2004-836225 pmid:15744624

    CrossRefPubMed
17. 17.↵
    2. Lee EJ,
    3. Kim JH,
    4. Park ES, et al

    . A novel weighted scoring system for estimating the risk of rapid growth in untreated intracranial meningiomas. J Neurosurg 2017;127:971–80 doi:10.3171/2016.9.JNS161669 pmid:28084908

    CrossRefPubMed
18. 18.↵
    2. Nakasu S,
    3. Nakasu Y

    . Natural history of meningiomas: review with meta-analyses. Neurol Med Chir (Tokyo) 2020;60:109–20 doi:10.2176/nmc.ra.2019-0213] pmid:32009127

    CrossRefPubMed
19. 19.↵
    2. Niiro M,
    3. Yatsushiro K,
    4. Nakamura K, et al

    . Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiatry 2000;68:25–28 doi:10.1136/jnnp.68.1.25 pmid:10601396

    Abstract/FREE Full Text
20. 20.↵
    2. Nakamura M,
    3. Roser F,
    4. Michel J, et al

    . The natural history of incidental meningiomas. Neurosurgery 2003;53:62–70; discussion 70–71 doi:10.1227/01.neu.0000068730.76856.58 pmid:12823874

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Hashiba T,
    3. Hashimoto N,
    4. Izumoto S, et al

    . Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas. J Neurosurg 2009;110:675–84 doi:10.3171/2008.8.JNS08481 pmid:19061353

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Oya S,
    3. Kim SH,
    4. Sade B, et al

    . The natural history of intracranial meningiomas. J Neurosurg 2011;114:1250–56 doi:10.3171/2010.12.JNS101623

    CrossRefPubMed
23. 23.↵
    2. Jadid KD,
    3. Feychting M,
    4. Höijer J, et al

    . Long-term follow-up of incidentally discovered meningiomas. Acta Neurochir (Wien) 2015;157:225–30 doi:10.1007/s00701-014-2306-3 pmid:25503298

    CrossRefPubMed
24. 24.↵
    2. Romani R,
    3. Ryan G,
    4. Benner C, et al

    . Non-operative meningiomas: long-term follow-up of 136 patients. Acta Neurochir (Wien) 2018;160:1547–53 doi:10.1007/s00701-018-3554-4 pmid:29876678

    CrossRefPubMed
25. 25.↵
    2. Yano S,
    3. Kuratsu JI

    . Kumamoto Brain Tumor Research Group. Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg 2006;105:538–43 doi:10.3171/jns.2006.105.4.538 pmid:17044555

    CrossRefPubMed
26. 26.↵
    2. Sughrue ME,
    3. Rutkowski MJ,
    4. Aranda D, et al

    . Treatment decision making based on the published natural history and growth rate of small meningiomas. J Neurosurg 2010;113:1036–42 doi:10.3171/2010.3.JNS091966 pmid:20433281

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Al-Mefty O,
    3. McDermott MW,
    4. DeMonte F

    . Al-Mefty's Meningiomas. 2nd ed. Thieme Medical; 2011
28. 28.↵
    2. Meling TR,
    3. Da Broi M,
    4. Scheie D, et al

    . Meningiomas: skull base versus non-skull base. Neurosurg Rev 2019;42:163–73 doi:10.1007/s10143-018-0976-7 pmid:29627874

    CrossRefPubMed
29. 29.↵
    2. van Griethuysen JJ,
    3. Fedorov A,
    4. Parmar C, et al

    . Computational radiomics system to decode the radiographic phenotype. Cancer Res 2017;77:e104–07 doi:10.1158/0008-5472.CAN-17-0339 pmid:29092951

    Abstract/FREE Full Text
30. 30.↵
    2. Islim AI,
    3. Mohan M,
    4. Moon RDC, et al

    . Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes. J Neurooncol 2019;142:211–21 doi:10.1007/s11060-019-03104-3 pmid:30656531

    CrossRefPubMed
31. 31.↵
    2. He JQ,
    3. Iv M,
    4. Li G, et al

    . Noncontrast T2-weighted magnetic resonance imaging sequences for long-term monitoring of asymptomatic convexity meningiomas. World Neurosurg 2020;135:e100–05 doi:10.1016/j.wneu.2019.11.051 pmid:31734418

    CrossRefPubMed
32. 32.↵
    2. Hashimoto N,
    3. Rabo CS,
    4. Okita Y, et al

    . Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies. J Neurosurg 2012;116:574–80 doi:10.3171/2011.11.JNS11999 pmid:22175721

    CrossRefPubMed